Shourong Wu Selected Research

Shourong Wu Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2007
6	Carcinogenesis 03/2022 - 01/2008
4	Ischemia 01/2022 - 01/2015
3	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 10/2019
3	Hyperglycemia 01/2020 - 01/2019
3	Hypoxia (Hypoxemia) 01/2019 - 07/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Myocardial Infarction 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Hemorrhage 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Diabetes Mellitus 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Foot Ulcer 01/2019
1	Carcinoma (Carcinomatosis) 08/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Chronic Limb-Threatening Ischemia 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 10/2013
1	Brain Neoplasms (Brain Tumor) 10/2013
1	Ovarian Neoplasms (Ovarian Cancer) 01/2011
1	Adenocarcinoma 07/2010

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 03/2022 - 01/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021 - 01/2019
3	EnzymesIBA 12/2021 - 01/2018
3	Pharmaceutical PreparationsIBA 08/2018 - 01/2011
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2021
2	rhodiolosideIBA 01/2022 - 01/2019
2	LipidsIBA 12/2021 - 01/2019
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 12/2021 - 01/2018
2	Neurogenic differentiation factor 1IBA 12/2021 - 01/2020
2	Heme Oxygenase-1IBA 01/2019 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2018 - 01/2011
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2015 - 07/2008
2	Small Interfering RNA (siRNA)IBA 01/2015 - 07/2010
2	MicellesIBA 10/2013 - 01/2011
2	PlatinumIBA 10/2013 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2010 - 07/2008
1	GlycosidesIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	NucleotidesIBA 12/2021
1	NADP (NADPH)IBA 12/2021
1	AntioxidantsIBA 12/2021
1	CoagulantsIBA 01/2021
1	FibrinIBA 01/2021
1	ChromatinIBA 01/2020
1	dapagliflozinIBA 01/2020
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	4-hydroxyphenylethanolIBA 01/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 08/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 08/2018
1	Peptides (Polypeptides)IBA 10/2013
1	LigandsIBA 10/2013
1	IntegrinsIBA 10/2013
1	cyclic arginine-glycine-aspartic acid peptideIBA 10/2013
1	arginyl-glycyl-aspartic acidIBA 10/2013
1	alanylaspartic acidIBA 10/2013
1	YY1 Transcription FactorIBA 03/2013
1	PAsp(DET)IBA 07/2010
1	Indicators and Reagents (Reagents)IBA 07/2010

Therapy/Procedure

6	Therapeutics 01/2021 - 07/2010
1	Limb Salvage 01/2020
1	Surgical Amputation (Amputations) 01/2019
1	Transplantation 01/2019
1	Intramuscular Injections 01/2015
1	Lasers (Laser) 10/2013